Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Reply Ob/Gyn & Fertility Clinic Imports Sensiplan, Making this German Fertility Awareness Method Available for the First Time to American Women
  • USA - English


News provided by

Juliette Weiland & Co.

Sep 28, 2017, 04:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Rachel Urrutia, Director of Reply's Sensiplan Program
Dr. Rachel Urrutia, Director of Reply's Sensiplan Program

Cary, North Carolina (PRWEB) September 28, 2017 -- Reply Ob/Gyn & Fertility, PLLC, launches patient education of Sensiplan to Raleigh-area patients in North Carolina, culminating two years of training with German medical instructors. Sensiplan is a fertility awareness method used throughout Europe but never before available in the U.S. At the only clinic in North America licensed to do so, Reply fertility educators are now teaching Sensiplan to couples seeking to avoid pregnancy naturally and effectively.

Sensiplan, a fertility awareness tool, has the highest effectiveness rates reported in medical journals.

Post this

“One of the things that makes Reply special is our commitment to patient education,” says clinic medical director, Dr. John M. Thorp. “When you teach a woman fertility awareness, you’re providing a tool she can use over the course of her reproductive years. We’re excited to make this new tool available to women in the triangle region.”

First in the United States to offer Sensiplan, the Reply clinic is located in Cary, North Carolina, just outside of Raleigh.

Reply ob/gyn Dr. Rachel Urrutia, also an assistant professor at UNC Chapel Hill Department of Obstetrics and Gynecology, is director of Reply’s Sensiplan program. She explains why the clinic went to the effort to import this German method:

“Fertility awareness is a great tool that can help women become pregnant, or avoid pregnancy,” said Dr. Rachel Urrutia, “but not all fertility awareness methods have been studied and found to be effective. Sensiplan has the highest effectiveness rates reported in medical journals, which is why we chose to bring this method over from Germany. To us it was important to have that foundation of research and validation for our patients.”

Sensiplan was studied at the University of Dusseldorf, including tracking of more than 9000 cycles among 900 women of reproductive age. Only one to two women per 100 women became pregnant during their first year using the method. This is on par with effective rates for conventional contraception.

Fertility awareness for avoiding pregnancy works by teaching women how to track and understand signs of fertility (e.g., basal body temperature, cervical mucus, menstruation) during the female reproductive cycle. Women and couples can use this information to identify which days are fertile, and then decide whether to attempt or avoid pregnancy.

“We’re going back to the basics, and teaching women how their bodies work,” says Reply Director of Education, Lori Hartley. “It’s incredibly exciting to see how empowered women are with this information. This really can revolutionize women’s healthcare.”

Benefits of Sensiplan and other fertility awareness methods for avoiding pregnancy include:
• all natural
• no side effects
• does not require pill taking, injections, insertions, barriers, or surgeries
• promotes learning and self-care
• compatible with world’s major religions

About Reply Ob/Gyn & Fertility

Reply Ob/Gyn & Fertility, PLLC, is a new kind of ob/gyn clinic that features fertility awareness and a cooperative approach to clinical care. Services include gynecology, obstetrics (featuring CenterPregnancy group prenatal care), patient education, and health coaching. The Reply team has developed its own fertility awareness method, Listen Fertility, for health monitoring and for women/couples trying to conceive. Reply also has licensed the German fertility awareness method, Sensiplan, introducing it for the first time in the United States. Clinic development was led by Dr. John M. Thorp, Division Director of General Obstetrics and Gynecology and Vice Chair of Research in the Department of Obstetrics and Gynecology at UNC Chapel Hill. Website is http://www.replyobgyn.com.

Contact:
Nancy DeMaria
Director of Marketing and Public Relations
Reply Ob/Gyn & Fertility
919-230-2100
ndemaria(at)replyobgyn(dot)com

Juliette Weiland, Juliette Weiland & Co., http://www.jweilandcompany.com, +1 (704) 843-0325, [email protected]

Modal title

Dr. John Thorp, Clinic Medical Director for Reply Ob/Gyn & Fertility, PLLC
Dr. John Thorp, Clinic Medical Director for Reply Ob/Gyn & Fertility, PLLC
Lori Hartley, MPH, RN, Director of Education, Reply Ob/Gyn & Fertility, PLLC
Lori Hartley, MPH, RN, Director of Education, Reply Ob/Gyn & Fertility, PLLC
Dr. John Thorp, Clinic Medical Director for Reply Ob/Gyn & Fertility, PLLC Lori Hartley, MPH, RN, Director of Education, Reply Ob/Gyn & Fertility, PLLC

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.